TABLE 1

Characteristics of participants for tuberculosis (TB) screening

VariablesAll participantsTSTIGRAAbsentees
Children44726216817
Age range years
 ≤514 (3.13%)12 (85.71%)1 (7.14%)1 (7.14%)
 6–12278 (62.19%)174 (62.59%)95 (34.17%)9 (3.24%)
 13–18155 (34.68%)76 (49.03%)72 (46.45%)7 (4.52%)
Sex
 Male245 (54.81%)148 (60.41%)83 (33.88%)14 (5.71%)
 Female202 (45.19%)114 (56.44%)85 (42.08%)3 (1.49%)
BCG status
 Vaccinated285 (66.28%)184 (64.56%)101 (35.44%)
 Not vaccinated145 (33.72%)78 (53.79%)67 (46.21%)
TB burden region
 High373 (86.74%)224 (60.05%)149 (39.95%)
  Bangladesh3 (0.70%)2 (66.67%)1 (33.33%)
  Cambodia3 (0.70%)03 (100%)
  India4 (0.93%)4 (100%)0
  Indonesia24 (5.58%)3 (12.50%)21 (87.50%)
  Liberia2 (0.47%)2 (100%)0
  Myanmar274 (63.72%)169 (61.68%)105 (38.32%)
  Pakistan60 (13.95%)44 (73.33%)16 (26.67%)
  The Philippines3 (0.70%)03 (100%)
 Intermediate57 (13.26%)38 (66.67%)19 (33.33%)
  Iran1 (0.23%)1 (100%)0
  Malaysia32 (7.44%)25 (78.13%)7 (21.87%)
  Sri Lanka23 (5.35%)12 (52.17%)11 (47.93%)
  UAE1 (0.23%)01 (100%)

TST: tuberculin skin test; IGRA: interferon-γ release assay; BCG: bacille Calmette–Guérin; UAE: United Arab Emirates.